ABSTRACT Background: Emerging evidence indicates that metabolic hormones are present in human milk, but, to our knowledge, no studies have investigated the impact of maternal metabolic status assessed during pregnancy on insulin and adiponectin concentrations in milk. Objectives: We aimed to investigate the associations of prenatal metabolic abnormalities with insulin and adiponectin in human milk and to compare the concentrations of these hormones in early and mature milk. Design: Pregnant women aged 20 y with intention to breastfeed and without preexisting type 1 or 2 diabetes were recruited. Participants (n = 170) underwent a 3-h oral-glucose-tolerance test at 30 wk (95% CI: 25, 33 wk) gestation and donated early (the first week postpartum) and mature (3 mo postpartum) milk. Results: Adiponectin and insulin concentrations in early milk were higher than those in mature milk (both P , 0.0001). Prenatal metabolic abnormalities, including higher pregravid BMI (b 6 SEE: 0.053 6 0.014; P = 0.0003) and gravid hyperglycemia (0.218 6 0.087; P = 0.01), insulin resistance (0.255 6 0.047; P , 0.0001), lower insulin sensitivity (20.521 6 0.108; P , 0.0001), and higher serum adiponectin (0.116 6 0.029; P , 0.0001), were associated with higher insulin in mature milk after covariate adjustment. Prenatal metabolic measures were not associated with milk adiponectin, but obstetrical measures that included nulliparity (0.171 6 0.058; P = 0.004), longer duration of gestation (0.546 6 0.146; P = 0.0002), and unscheduled cesarean delivery (0.387 6 0.162; P = 0.02) were associated with higher adiponectin in early milk after covariate adjustment, including the time elapsed from delivery to milk collection. Conclusion: Maternal prenatal metabolic abnormalities are associated with high insulin concentrations in mature milk, whereas only obstetrical variables are associated with adiponectin concentrations in early milk. This trial was registered at clinicaltrials.gov as NCT01405547.
INTRODUCTION
The WHO recommends breastfeeding as the ideal food source for the growth and development of infants and an integral part of the reproductive process (1) . Breastfeeding has been shown to have beneficial effects on short-and long-term maternal and infant health outcomes (2) . For example, lactation has been shown to have beneficial effects on maternal glucose metabolism (3) (4) (5) . In addition, epidemiologic evidence has shown a long-term protective effect of breastfeeding against obesity and type 2 diabetes in offspring (6) (7) (8) . Although recommendations for optimal breastfeeding practices continue to be revisited (9) , evidence that links maternal metabolic abnormalities with human milk components is limited.
In an observational study from Germany, infants were supplemented with donor human milk from women with normal glucose tolerance when their own mothers with diabetes were not able to provide an adequate amount of milk (10) . Children who consumed a higher amount of milk from mothers with diabetes during the first week of life were at higher risk of overweight at 2 y of age (10) . The authors suggested that the early neonatal ingestion of milk from mothers with diabetes might have contributed to observed childhood overweight, but components in human milk that might be responsible for this effect were not investigated in this study (10) . Human milk contains not only macro and micronutrients but also an array of bioactive substances that include insulin (11, 12) . More recently, adiponectin, which is an insulin-sensitizing hormone in serum (13) , was detected in human milk (14) (15) (16) . Previous studies have shown that oral administration of insulin early in life stimulates gut maturation (17) , and that adiponectin receptors are present in the human intestine (18) . These hormones in milk might locally or systemically regulate tissue activities of neonates while the endocrine system matures (19) and therefore contribute to the observed association of breastfeeding with reduced risk of metabolic disease later in life (2) .
The WHO (1) and local organizations for obstetrics and pediatrics (9, 20) encourage women to breastfeed but do not provide specific breastfeeding-practice recommendations for women with metabolic abnormalities during pregnancy. Because emerging evidence indicates that metabolic hormones are present in human milk (12, (14) (15) (16) and the offspring of women with GDM 5 are at increased long-term risk of type 2 diabetes (21, 22) , the impact of maternal metabolic status on these milk hormones would be of interest to document. Although a number of studies have detected insulin and adiponectin in human milk (12, (14) (15) (16) , to our knowledge, none of the studies have investigated the impact of maternal metabolic status assessed during pregnancy on these milk hormone concentrations. We therefore tested our hypotheses that maternal metabolic abnormalities in pregnancy (ie, overweight, insulin resistance or lower insulin sensitivity, and glucose intolerance) would be associated with compromised concentrations of milk insulin and adiponectin, and concentrations of these hormones would be higher in early milk during the first week compared with mature milk at 3 mo postpartum.
SUBJECTS AND METHODS

Study design
Between March 2009 and July 2010, pregnant women were recruited from the outpatient clinics at the Mount Sinai Hospital (Toronto, Canada), which is a tertiary care center (23) . The inclusion criterion for the current investigation was women aged 20 y who intended to breastfeed. Women who reported preexisting type 1 or 2 diabetes, current use of insulin, or completion of an OGTT before recruitment during the current pregnancy were excluded. Signed informed consent was obtained from all participants, and the study was approved by the Mount Sinai Hospital Research Ethics Board.
Of 216 recruited women who completed a 3-h OGTT during a current pregnancy, 170 women who donated at least one human milk sample were included in the current analysis. Women who did not provide a milk sample (n = 46) compared with those who did provide a milk sample at least once (n = 170) had slightly higher gestational weight gain and insulin resistance during pregnancy but were not different in age, pregravid BMI (in kg/m 2 ), and SES (see Supplemental Table 1 under "Supplemental data" in the online issue). Of 170 women who donated milk at least once, 53 individuals (31.2%) were unable to donate a mature milk sample at the 3-mo visit [35 women (20.6%) did not respond to the 3-mo follow-up invitation, 14 women (8.2%) reported that they had discontinued providing their milk to infants, and 4 women (2.4%) reported continued breastfeeding but declined to donate milk samples]. Women who did not provide a milk sample at 3 mo postpartum (n = 53) compared with women who did (n = 117) had slightly higher pregravid BMI, insulin resistance during pregnancy, and lower SES but were not different in age, ethnicity, and gestational age at delivery.
Milk collection
On delivery, participants were visited in the hospital to collect a sample of early milk. Early milk was collected by using hand expression or an electric breast pump (Medela Electric Double Breastpump; Medela Inc), whichever was preferred by the participant. If the participating woman was unable to express early milk during the hospital stay, a home visit was conducted by study personnel to collect early milk samples up to 7 d postpartum (first 24 h was defined as day 0). Of 164 early milk samples, 18 samples (11.0%) were collected at a home visit.
At 3 mo postpartum, participating women were invited to the study unit to donate a mature milk sample. Women were asked not to breastfeed or pump their milk for 2 h before the study visit. During the study visit, participants were asked to perform complete breast expression from both breasts by using the double electric breast pump assisted by study personnel. Of 117 milk samples collected at the 3-mo study visit, 10 samples (8.5%) were collected at a home visit. Milk samples were stored at 280°C until biochemical analysis.
Biochemical analysis of milk samples
Milk samples were thawed and centrifuged (1600 · g for 20 min at room temperature), and the fat layer was removed to prepare skim milk. Total adiponectin in skim milk was measured by using a radioimmunoassay (Millipore; Linco Research). This assay has an interassay CVof 9.3% at a concentration of 7.5 lg/L. The detailed protocol and validation of the milk adiponectin assay have been published previously (24) . Insulin in skim milk was measured by using an electrochemiluminescence immunoassay (Roche Modular Analytics E170; Roche). This assay shows 0.05% cross-reactivity to intact human proinsulin and the primary circulating split form. Glucose in skim milk was determined by using the hexokinase enzymatic method (Roche Modular Analytics E170; Roche). Total protein in skim milk was measured by using a bicinchoninic acid protein assay kit (Sigma) (25) . Total fat in whole milk was determined by using the creamatocrit methodology described by Lucas et al (26) .
Assessment of metabolic status during pregnancy
Women who participated in the study underwent a 3-h 100-g OGTT at 30 wk (95% CI: 25, 33 wk) of gestation during which blood samples were drawn at fasting and at 60, 120, and 180 min postload. Serum glucose was determined by using the hexokinase enzymatic method (Roche Modular Analytics E170; Roche). Serum insulin was measured by using an electrochemiluminescence immunoassay (Roche Modular Analytics E170; Roche). Serum total adiponectin was measured by using a radioimmunoassay (Millipore; Linco Research).
Women were diagnosed with GDM according to the National Diabetes Data Group criteria (27) as having 2 of the following: fasting glucose concentration 5.8 mmol/L, 1-h blood glucose concentration 10.6 mmol/L, 2-h blood glucose concentration 9.2 mmol/L, or 3-h blood glucose concentration 8.1 mmol/L. Insulin sensitivity was assessed by using the ISogtt, which is an established measure of wholebody insulin sensitivity that has been validated against the euglycemic-hyperinsulinemic clamp (28 
Other variables
Height and weight were measured at the time of the 3-h OGTT according to standardized anthropometric protocols (30) , and self-reported pregravid weight was recorded. Questionnaires were administrated at the time of the 3-h OGTT to obtain demographic, medical, dietary, physical activity, and smoking information. The SES index was generated by using an occupational scale calibrated for the Canadian National Occupational Classification system (31) . Dietary intake was collected by using a modified Block food-frequency questionnaire, which was originally developed by Block et al (32, 33) Participants were asked to recall their dietary intake during the second trimester of the current pregnancy, which was defined as 13-26 wk of gestation (34) . Pregravid physical activity in the year before pregnancy was obtained by using the Baecke questionnaire, which has been validated in several populations including in women of childbearing age (35, 36) . A questionnaire was administered after delivery to obtain information about the mode of delivery and last reported weight during pregnancy to assess gestational weight gain.
Statistical analysis
Distributions of continuous variables were assessed for normality, and ln transformations of skewed variables were used in subsequent analyses. Descriptive statistics for continuous variables were summarized as means 6 SDs or medians (25th, 75th percentiles) for variables with a skewed distribution. Categorical variables were summarized by using proportions. Characteristics of participants according to pregravid overweight status (BMI ,25 compared with 25) were compared by using Welch's modified t test or chi-square test as appropriate. Concentrations of insulin and adiponectin in early and mature milk were compared by using paired t tests with data from women who donated milk at both the first-week and 3-mo postpartum visits. To assess correlations of adiponectin and insulin with milk components, Spearman's rank correlation analysis was performed.
General linear models were used to assess associations of hormones in first-week and 3-mo milk with prenatal maternal metabolic variables, including pregravid BMI, gestational weight gain, serum fasting glucose, HOMA-IR, ISogtt, adiponectin, and GDM status, and with obstetrical variables, including nulliparity (yes or no), mode of delivery (spontaneous, scheduled, and unscheduled cesarean delivery), and length of gestation (continuous weeks). Each milk hormone was tested separately with adjustment for age (continuous years), ethnicity (European and non-European descent), and the time elapsed from delivery to milk collection (continuous hours in early milk and days in mature milk). The time elapsed from delivery to milk collection was included as a covariate because metabolic milk-hormone concentrations may vary considerably during the first week (12) . To assess these associations specifically within colostrum samples, a sensitivity analysis of early milk samples with restriction to samples collected at 0-3 d postpartum was performed.
To assess whether pregravid BMI influenced associations of interest, we tested whether pregravid BMI modified associations of maternal metabolic and obstetrical exposures with milk hormones. The interaction testing was performed by adding an interaction term into a model adjusted for age, ethnicity, and the time elapsed from delivery to milk collection. For all statistical analyses, 2-sided P , 0.05 was considered to be statistically significant, except for interaction terms for which P , 0.01 was used to reduce the likelihood of false-positive interactions. All data analyses were performed with SAS software (version 9.2; SAS Institute).
RESULTS
The characteristics of participants according to pregravid overweight status are presented in Table 1 . Of 170 participants who donated milk samples, 66 of women (38.8%) had a pregravid BMI 25. Characteristics of women with a pregravid BMI 25 were not different from those of women with a pregravid BMI ,25 except for higher HOMA-IR and lower ISogtt (both P 0.007; Table 1 ).
Concentrations of milk components at 2 different study visits
Concentrations of components in early milk collected at a median of 2 d (25th, 75th percentiles: 1, 3 d) and mature milk collected at a median of 95 d (91, 102 d) are shown in Table 2 . Early milk samples had higher adiponectin, insulin, and total protein and lower glucose and total fat concentrations than did mature milk samples (unpaired t test; all P , 0.0001). Similarly, in analyses restricted to participants who donated milk samples at both visits, early milk samples had higher adiponectin, insulin, and total protein and lower glucose and total fat concentrations than did mature milk samples (paired t test; all P , 0.0001) (Figure 1 for adiponectin and Figure 2 for insulin). The reductions in milk adiponectin and insulin concentrations from early to mature milk remained significant with adjustment for total protein concentrations in both paired and unpaired analyses (all P 0.002).
In early milk, the adiponectin concentration was positively correlated with total protein (Spearman's correlation coefficient r = 0.58) and inversely correlated with glucose (r = 20.47) and total fat (r = 20.44) (all P , 0.0001), and insulin was inversely correlated with total fat (r = 20.24; P = 0.005) (see Supplemental Table 2 under "Supplemental data" in the online issue). In mature milk, adiponectin was inversely correlated with glucose (r = 20.21, P = 0.025).
Assessment of maternal prenatal metabolic and obstetrical measures with milk adiponectin
Prenatal metabolic variables were not associated with adiponectin concentrations in early or mature milk, except for serum adiponectin ( Table 3) . A higher maternal serum adiponectin concentration during pregnancy was associated with higher adiponectin in early milk (b 6 SEE: 0.102 6 0.032; P = 0.002) and in mature milk (0.045 6 0.020; P = 0.03) with adjustment for maternal age, ethnicity, and the time elapsed from delivery to milk collection. When the analysis of early milk was restricted specifically to colostrum samples collected at 0-3 d postpartum (n = 136), adiponectin in colostrum remained significantly associated with serum adiponectin with multiple adjustment (0.103 6 0.038; P = 0.009) (see Supplemental Table 3 under "Supplemental data" in the online issue).
Additional adjustment of the multiple regression models for BMI at the time of OGTT, SES index, pregravid physical activity index, gestational average daily energy intake, or smoking status did not change the significant associations of serum adiponectin during pregnancy with adiponectin in early and mature milk, except for the association of serum adiponectin with mature milk adiponectin, which became attenuated to nonsignificance after additional adjustment for BMI at the time of OGTT (0.037 6 0.021; P = 0.07).
Nulliparity and longer duration of gestation were associated with higher adiponectin concentrations in early milk with adjustment for maternal age, ethnicity, and the time elapsed from delivery to milk collection [b 6 SEE: 0.171 6 0.058 (P = 0.004) and 0.546 6 0.146 (P = 0.0002), respectively] ( Table 3) . Having an unscheduled cesarean delivery was associated with higher adiponectin concentrations in early milk with multiple adjustment (0.387 6 0.162; P = 0.02), whereas a scheduled cesarean delivery was associated with lower adiponectin concentrations in early milk (20.422 6 0.186; P = 0.02) ( Table 3 ). In the analysis restricted to colostrum samples collected 0-3 d postpartum (n = 136), these associations remained significant, except for the association of scheduled cesarean delivery, which was attenuated to nonsignificance (20.402 6 0.215; P = 0.06) (see Supplemental  Table 3 under "Supplemental data" in the online issue). Obstetrical variables listed in Table 3 were not associated with adiponectin concentrations in mature milk. Additional adjustment of the multiple regression models for last gravid BMI (calculated from the last pregnancy weight reported), SES index, pregravid physical activity index, gestational average daily energy intake, or smoking status did not change the significant associations of nulliparity, having a scheduled or unscheduled cesarean delivery, and the duration of gestation with adiponectin in early milk. In addition, pregravid BMI did not modify associations of maternal metabolic status during pregnancy and obstetrical measures with milk adiponectin.
Assessment of maternal prenatal metabolic and obstetrical measures with milk insulin
Higher pregravid BMI was associated with higher insulin concentrations in mature milk with adjustment for maternal age, ethnicity, and the time elapsed from delivery to milk collection (b 6 SEE: 0.053 6 0.014; P = 0.0003) ( Table 4 ). Higher serum fasting glucose (0.218 6 0.087; P = 0.01) and HOMA-IR (0.255 6 0.047; P , 0.0001) and lower ISogtt (20.521 6 0.108; P , 0.0001) and serum adiponectin (20.116 6 0.029; P , 0.0001) during pregnancy were associated with higher insulin concentrations in mature milk with multiple adjustment (Table 4) . Maternal metabolic status was not associated with insulin concentrations in early milk (Table 4 ). In the analysis restricted to colostrum samples collected at 0-3 d postpartum (n = 135), these associations remained nonsignificant (see Supplemental Table 3 under "Supplemental data" in the online issue).
Additional adjustment of multiple regression models for SES index, pregravid physical activity index, gestational average daily energy intake, or smoking status did not change the significant associations of pregravid BMI, serum fasting glucose, HOMA-IR, ISogtt, and adiponectin with insulin in mature milk. Associations of HOMA-IR, ISogtt, and adiponectin with mature milk insulin remained significant with additional adjustment for BMI at the OGTT, but the association of serum fasting glucose with mature milk insulin became attenuated to nonsignificance after additional adjustment for BMI at the OGTT (0.166 6 0.087; P = 0.06).
Nulliparity was associated with lower insulin concentrations in mature milk with adjustment for maternal age, ethnicity, and the time elapsed from delivery to milk collection (b 6 SEE: 20.310 6 0.144; P = 0.03) ( Table 4 ). Additional adjustment of the multiple regression model for pregravid physical activity index attenuated this association between nulliparity and insulin in mature milk to non significance (20.283 6 0.150; P = 0.06). Obstetrical variables were not associated with insulin concentrations in early milk (Table 4 ) or in colostrum (see Supplemental Table 3 under "Supplemental data" in the online issue).
No statistical interactions of maternal metabolic status during pregnancy and obstetrical measures with a pregravid BMI on milk insulin were present, except for a significant interaction with ISogtt on the outcome of insulin in early milk (P-interaction = 0.003). When regression analysis for ISogtt with insulin in early milk was stratified by pregravid BMI status, low ISogtt during pregnancy was associated with high insulin in early milk in women with a pregravid BMI ,25 (b 6 SEE: 20.597 6 0.221; P = 0.008), but this association was not present in women with a pregravid BMI 25.
DISCUSSION
In this study, adiponectin and insulin concentrations were higher in early milk compared with mature milk. In addition, prenatal metabolic measures, including higher pregravid BMI and gravid hyperglycemia, insulin resistance, lower insulin sensitivity, and higher serum adiponectin, were associated with higher insulin concentrations in mature milk, whereas these factors were not associated with insulin concentrations in early milk. Prenatal metabolic measures were not associated with adiponectin in human milk, except for serum adiponectin. However, obstetrical variables, including nulliparity, longer duration of gestation, and an unscheduled cesarean delivery, were associated with a higher adiponectin concentration in early milk.
In addition to nutrients, a number of metabolic hormones including insulin, adiponectin, leptin, and ghrelin are present in human milk (11, 12, 14, 37, 38) . In serum, these hormones regulate energy balance (39, 40) and obesity-induced inflammatory signaling pathways that contribute to type 2 diabetes (41). Although these metabolic hormones have been detected in human milk (11, 12, 14, 37, 38) , limited information has been reported on whether these milk hormones are influenced by maternal metabolic status. A study reported that ghrelin concentrations in colostrum at 2 d postpartum were lower in women who had GDM than in women without diabetes, but the difference was not observed in mature milk (42) . This study suggested that the offspring of mothers who experience metabolic abnormalities during pregnancy might be exposed to compromised early nutrition. However, the study was limited by a small sample size (GDM, n = 12; no diabetes, n = 14) which precluded adjustment for potential confounders. Because metabolic milk hormone concentrations during the first week postpartum vary considerably (12), variation in the time elapsed from delivery to milk collection might have influenced the differences reported. In the current investigation, which involved a larger number of colostrum samples, metabolic status did not influence insulin and adiponectin concentrations in early milk after multiple adjustment, including the time elapsed from delivery to milk collection. However, adiponectin in early milk was associated with obstetrical variables in our investigation. Because women with diabetes have been shown to experience higher rates of delivery complications, including cesarean delivery (22) , it is possible that women with GDM in the previous investigation might have experienced obstetrical complications, thereby indirectly influencing metabolic hormone concentrations in milk. However, obstetrical variables were not reported in that study (42) . In another study, infants were supplemented with donor human milk from women with normal glucose tolerance when their own mothers with diabetes were not able to provide an adequate amount of milk. Children who consumed a higher amount of human milk from mothers with diabetes (type 1 diabetes, n = 83; GDM, n = 29) during the first week of life were more likely to have a higher percentage of relative body weight at 2 y of age (10) . Therefore, the authors suggested that the early neonatal ingestion of milk from mothers with diabetes might increase risk of childhood overweight. However, specific components in human milk that might have contributed to this difference were not investigated in the study. In addition, findings from the study of donor human milk supplementation are difficult to interpret and generalize to other practice settings because donor milk handling processes can alter concentrations of milk components (24, 43) . Although the molecular mechanisms through which these metabolic hormones in milk may provide protection against the development of obesity and type 2 diabetes in offspring later in life are not completely understood, the potential physiologic roles of these hormones in influencing infant metabolic trajectories have been reviewed (17, 44, 45) . Evidence indicates that oral administration of insulin early in life stimulates gut maturation (17) , and adiponectin receptors are present in the human intestine (18) . In addition, the characteristics of the infant gastrointestinal tract, including delayed production of pancreatic proteases and gastric acid and higher permeability to macromolecules, in addition to the presence of antiproteases and inhibitors in human milk, would allow for survival and absorption of human milk components (46) (47) (48) . These milk metabolic hormones may have a role through local or systemic mechanisms that regulate the development of infants and subsequently in the reduction of the susceptibility to future metabolic disease. Therefore, the consumption of compromised concentrations of metabolic hormones in human milk could have short-and long-term implications in offspring.
Previous studies have reported the detection of insulin and adiponectin in human milk (12, (14) (15) (16) , but, to our knowledge, no studies have investigated the impact of maternal metabolic status assessed during pregnancy on these hormone concentrations in human milk. In this study, we report that these milk hormones were influenced by maternal prenatal metabolic status by using detailed assessments of gravid metabolic and obstetrical variables. In addition, we were able to obtain milk samples at 2 clearly defined periods of lactation (during the first week and at 3 mo postpartum) from the women in this study to investigate the impact of prenatal metabolic and obstetrical variables on human milk. However, the current study had limitations. Because a number of participants experienced difficulty expressing their colostrum shortly after delivery, we had variation in the number of hours elapsed between delivery and early milk collection. To account for this variation, we included adjustment for the time elapsed from delivery to milk collection in multiple regression analysis, and in addition, we performed a subanalysis in participants who donated early milk within first 3 d postpartum.
Another methodologic limitation of our study was that pregravid BMI and gestational weight-gain variables were calculated by using measured height but self-reported weight. It is possible that overweight and obese women might have underreported weight (49) , which would have attenuated reported effect sizes by narrowing the degree of variation in reported weight. Also, we used an assay that detected total adiponectin and was not specific to the HMW form of adiponectin. In human serum, HMW adiponectin is known to be the most biologically active form and to have stronger associations with diabetes risk than total adiponectin (13) . However, adiponectin in human milk has been reported to be almost entirely composed of the HMW form (45) . Therefore, the total adiponectin in milk reported in the current study would likely have predominantly been the HMW form.
In conclusion, maternal prenatal metabolic abnormalities were associated with high insulin concentrations in mature milk, whereas only obstetrical variables were associated adiponectin concentrations in colostrum. Although these metabolic hormones were previously detected in human milk (12, 14-16), we report, for the first time to our knowledge, that these milk hormones are influenced by maternal prenatal metabolic status or obstetrical events by using samples assessed at 2 different periods of lactation. These findings indicate that a metabolically complicated pregnancy does not affect the metabolic hormone concentration in early milk and hence support current clinical practice in which all women, including those with prenatal metabolic abnormalities, are encouraged to breastfeed (1, 9, 20) . Our findings linking maternal prenatal metabolic abnormalities with elevated insulin in mature milk, in addition to recent evidence from a randomized controlled study that indicated long-term benefits of dietary intervention in infancy (50) , show the need for future investigations that assess the impact of compromised metabolic hormones in milk on the short-term metabolic development in infants and longterm susceptibility to obesity and type 2 diabetes later in life.
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